MVD is human diphosphomevalonate decarboxylase (mevalonate-5-diphosphate decarboxylase; EC 4.1.1.33), the enzyme that catalyses the final step of the mevalonate pathway. It performs the ATP-dependent decarboxylation of (R)-5-diphosphomevalonate (mevalonate-5-diphosphate) to isopentenyl diphosphate (IPP), releasing CO2, ADP and inorganic phosphate. IPP is the fundamental five-carbon (C5) isoprenoid building block from which all downstream isoprenoids are assembled, so MVD sits at the point where the mevalonate pathway delivers activated isoprene units for sterol (cholesterol) biosynthesis and for the non-sterol isoprenoid branches (dolichol, ubiquinone, and the prenyl groups used in protein prenylation). The protein is a member of the GHMP kinase superfamily, binds ATP, and functions as a homodimer of ~43-kDa subunits. It is a soluble cytosolic enzyme. In humans, loss-of-function and missense variants in MVD (together with MVK, the two principal porokeratosis genes) cause porokeratosis (POROK7), a disorder of faulty epidermal keratinization characterised by the cornoid lamella.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004163
diphosphomevalonate decarboxylase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core catalytic molecular function of MVD, propagated by phylogenetic inference across the diphosphomevalonate decarboxylase family and strongly corroborated by direct human experimental evidence.
Reason: This is the defining molecular function of MVD (EC 4.1.1.33): ATP-dependent decarboxylation of (R)-5-diphosphomevalonate to isopentenyl diphosphate. The IBA is consistent with human biochemical and structural characterization.
Supporting Evidence:
PMID:18823933
Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
file:human/MVD/MVD-uniprot.txt
Catalyzes the ATP dependent decarboxylation of (R)-5-
|
|
GO:0019287
isopentenyl diphosphate biosynthetic process, mevalonate pathway
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Precise biological process for MVD: it produces isopentenyl diphosphate (IPP) as the final step of the mevalonate pathway.
Reason: MVD's product is IPP, and the enzyme catalyses the terminal mevalonate-pathway step that generates it. This term captures the direct biological process at the correct level of specificity and is the best core BP term.
Supporting Evidence:
PMID:18823933
catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
file:human/MVD/MVD-uniprot.txt
Functions in
CC the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP)
|
|
GO:0005829
cytosol
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: MVD is a soluble cytosolic enzyme; the phylogenetically inferred cytosolic localization matches direct human experimental evidence.
Reason: Direct subcellular fractionation, immunofluorescence and immunoelectron microscopy established a cytosolic localization for human MVD, with no peroxisomal signal.
Supporting Evidence:
PMID:14972328
We found a
cytosolic localization for both endogenous human mevalonate pyrophosphate
decarboxylase
|
|
GO:0004163
diphosphomevalonate decarboxylase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (ARBA/InterPro/RHEA/EC) assignment of the core catalytic function, redundant with the experimental and IBA annotations.
Reason: Correctly maps the specific diphosphomevalonate decarboxylase activity (EC 4.1.1.33, RHEA:23732) to MVD; concordant with experimental evidence.
Supporting Evidence:
file:human/MVD/MVD-uniprot.txt
EC=4.1.1.33
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Broader cytoplasmic localization from the UniProt subcellular-location mapping; correct but less specific than cytosol.
Reason: UniProt annotates MVD as cytoplasmic, consistent with its established cytosolic localization. This parent term is correct though the more specific GO:0005829 (cytosol) is preferred.
Supporting Evidence:
file:human/MVD/MVD-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
|
|
GO:0005829
cytosol
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated cytosol localization consistent with experimental evidence.
Reason: Correct; MVD is cytosolic (established experimentally in PMID:14972328).
Supporting Evidence:
PMID:14972328
but no indication for a peroxisomal localization
|
|
GO:0008299
isoprenoid biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Broader isoprenoid biosynthesis framing; MVD produces IPP, the universal isoprenoid precursor.
Reason: True but general parent of the more precise GO:0019287. Retained as an accurate higher-level BP: MVD's product IPP is the substrate for all isoprenoid biosynthesis.
Supporting Evidence:
PMID:18823933
The reaction is required for production of polyisoprenoids and sterols from acetyl-CoA.
|
|
GO:0016831
carboxy-lyase activity
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: Broad InterPro2GO molecular-function parent of the specific diphosphomevalonate decarboxylase activity.
Reason: MVD is a decarboxylase (carboxy-lyase), so this term is not wrong, but it is an uninformative parent of the specific GO:0004163 diphosphomevalonate decarboxylase activity which is experimentally established. Replace with the specific term.
Proposed replacements:
diphosphomevalonate decarboxylase activity
Supporting Evidence:
PMID:18823933
catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
|
|
GO:0019287
isopentenyl diphosphate biosynthetic process, mevalonate pathway
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Automated (InterPro2GO) assignment of the precise mevalonate-pathway IPP biosynthesis process, redundant with the IBA.
Reason: Correct and specific; MVD produces IPP as the terminal mevalonate-pathway step.
Supporting Evidence:
file:human/MVD/MVD-uniprot.txt
Functions in
CC the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP)
|
|
GO:0006695
cholesterol biosynthetic process
|
IEA
GO_REF:0000041 |
KEEP AS NON CORE |
Summary: UniPathway-derived link to cholesterol biosynthesis. MVD feeds the sterol branch but its direct product is IPP, upstream of the sterol/non-sterol branch point.
Reason: Cholesterol biosynthesis is a downstream consequence of MVD activity rather than its direct process: MVD makes IPP, which supplies both sterol (cholesterol) and many non-sterol isoprenoid branches (dolichol, ubiquinone, prenyl groups). The accurate direct BP is the mevalonate-pathway IPP biosynthesis (GO:0019287). Retain as a valid non-core downstream pathway association.
Supporting Evidence:
file:human/MVD/MVD-uniprot.txt
a key precursor for the biosynthesis of isoprenoids and sterol
file:human/MVD/MVD-uniprot.txt
PATHWAY: Steroid biosynthesis; cholesterol biosynthesis.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:14972328 Human mevalonate pyrophosphate decarboxylase is localized in... |
ACCEPT |
Summary: Experimental cytoplasmic/cytosolic localization of human MVD.
Reason: Directly supported by the localization study; MVD is active in the cytosol (cytoplasm). GO:0005829 (cytosol) is the more specific form of the same finding.
Supporting Evidence:
PMID:14972328
We found a
cytosolic localization for both endogenous human mevalonate pyrophosphate
decarboxylase
|
|
GO:0004163
diphosphomevalonate decarboxylase activity
|
EXP
PMID:18823933 Human mevalonate diphosphate decarboxylase: characterization... |
ACCEPT |
Summary: Direct experimental characterization of recombinant human MVD's diphosphomevalonate decarboxylase activity, including kinetics and active-site mutagenesis, backed by a crystal structure.
Reason: Gold-standard experimental support for the core catalytic function. Kinetic parameters were measured and active-site residues (R161, N17) validated; R161Q causes ~1000-fold loss of activity.
Supporting Evidence:
PMID:18823933
Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
PMID:18823933
R161Q exhibits a approximately
1000-fold diminution in specific activity
|
|
GO:0004163
diphosphomevalonate decarboxylase activity
|
EXP
PMID:8626466 Molecular cloning and expression of the cDNAs encoding human... |
ACCEPT |
Summary: Cloning/expression paper showing recombinant human MVD has decarboxylase activity (2.4 units/mg).
Reason: Experimental confirmation of the core catalytic function; duplicate of the other GO:0004163 catalytic annotations.
Supporting Evidence:
PMID:8626466
The recombinant human enzyme is a
homodimer of 43-kDa subunits with a specific activity of 2.4 units/mg.
|
|
GO:0004163
diphosphomevalonate decarboxylase activity
|
EXP
PMID:9392419 Post-translational regulation of mevalonate kinase by interm... |
ACCEPT |
Summary: Recombinant human MDDase (MVD) was expressed, purified and assayed as part of a mevalonate-pathway feedback-inhibition study.
Reason: Experimental support for the decarboxylase activity; MVD's KM for (R)-5-diphosphomevalonate was determined. Duplicate of the core catalytic annotation.
Supporting Evidence:
PMID:9392419
mevalonate diphosphate decarboxylase (MDDase)
file:human/MVD/MVD-uniprot.txt
KM=7.4 uM for (R)-5-diphosphomevalonate {ECO:0000269|PubMed:9392419}
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-1655836 |
ACCEPT |
Summary: Reactome traceable assertion placing MVD in the cytosol.
Reason: Consistent with the experimentally established cytosolic localization of MVD.
Supporting Evidence:
PMID:14972328
Human mevalonate pyrophosphate decarboxylase is localized in the
cytosol.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-191414 |
ACCEPT |
Summary: Reactome traceable assertion (MVD decarboxylates MVA5PP to IPPP reaction) placing MVD in the cytosol.
Reason: Consistent with the experimentally established cytosolic localization; the cited Reactome reaction is exactly the MVD decarboxylation of mevalonate-5-diphosphate to IPP.
Supporting Evidence:
PMID:14972328
Human mevalonate pyrophosphate decarboxylase is localized in the
cytosol.
|
|
GO:0004163
diphosphomevalonate decarboxylase activity
|
IDA
PMID:11792727 Absence of functional peroxisomes does not lead to deficienc... |
ACCEPT |
Summary: MVD (MPD) decarboxylase activity measured directly in human/mouse tissue in a study of MVA-pathway enzyme activities.
Reason: Direct activity measurement of MVD supports the core catalytic function (duplicate of the other GO:0004163 annotations).
Supporting Evidence:
PMID:11792727
mislocalization of enzymes to the cytosol does not lead to decreased activity or
|
|
GO:0004163
diphosphomevalonate decarboxylase activity
|
IDA
PMID:14680974 Cholesterol biosynthesis is not defective in peroxisome biog... |
ACCEPT |
Summary: MVD (mevalonate pyrophosphate decarboxylase) activity measured directly among presqualene MVA/isoprenoid enzymes in PBD fibroblasts.
Reason: Direct activity measurement supports the core catalytic function (duplicate of the other GO:0004163 annotations).
Supporting Evidence:
PMID:14680974
mevalonate pyrophosphate decarboxylase
|
|
GO:0006695
cholesterol biosynthetic process
|
NAS
PMID:14680974 Cholesterol biosynthesis is not defective in peroxisome biog... |
KEEP AS NON CORE |
Summary: Author-stated (NAS) placement of MVD in the cholesterol/isoprenoid biosynthetic pathway.
Reason: MVD is one of the presqualene enzymes of the cholesterol/isoprenoid pathway, but cholesterol synthesis is downstream of MVD's direct product IPP (which also feeds non-sterol branches). Accurate as a non-core downstream pathway association; the precise direct BP is the mevalonate-pathway IPP biosynthesis.
Supporting Evidence:
PMID:14680974
five different
enzymes of the presqualene segment of the cholesterol/isoprenoid biosynthetic
pathway
|
|
GO:0008284
positive regulation of cell population proliferation
|
IMP
PMID:9270019 Regulation of proliferation and Ras localization in transfor... |
KEEP AS NON CORE |
Summary: Inhibiting MVD with 6-fluoromevalonate (Fmev) blocks production of downstream mevalonate products, prevents Ras prenylation/membrane localization, and suppresses proliferation of transformed cells.
Reason: This is a pathway-level, indirect effect: MVD activity is required to make IPP and hence the prenyl groups that drive Ras-dependent proliferation. It reflects a physiological consequence of MVD's metabolic role rather than a distinct signalling function of the protein. Retain as a non-core process rather than a core molecular function. Per curation policy this experimental (IMP) annotation is not removed.
Supporting Evidence:
PMID:9270019
6-fluoromevalonate (Fmev), an inhibitor of diphosphomevalonate decarboxylase
PMID:9270019
completely
prevented the proliferation of U-937 cells
|
|
GO:0008299
isoprenoid biosynthetic process
|
IDA
PMID:11792727 Absence of functional peroxisomes does not lead to deficienc... |
ACCEPT |
Summary: Experimental support for MVD participation in isoprenoid/cholesterol biosynthesis (MVA-pathway enzyme activities measured).
Reason: Broad but accurate: MVD produces IPP, the universal isoprenoid precursor. GO:0019287 is the more precise BP; this parent is retained as correct.
Supporting Evidence:
PMID:11792727
enzymes
involved in cholesterol biosynthesis
|
|
GO:0008299
isoprenoid biosynthetic process
|
IDA
PMID:14680974 Cholesterol biosynthesis is not defective in peroxisome biog... |
ACCEPT |
Summary: Experimental support for MVD participation in the cholesterol/isoprenoid biosynthetic pathway.
Reason: Accurate higher-level BP; MVD's product IPP is the isoprenoid building block. GO:0019287 is the precise process; this parent is retained as correct.
Supporting Evidence:
PMID:14680974
cholesterol/isoprenoid biosynthetic
pathway
|
|
GO:0030544
Hsp70 protein binding
|
IPI
PMID:12646231 Mortalin-MPD (mevalonate pyrophosphate decarboxylase) intera... |
MARK AS OVER ANNOTATED |
Summary: MVD (MPD) was identified in a yeast two-hybrid screen and co-IP as an interactor of mortalin (mot-2/GRP75), a member of the HSP70 family, in a study of proliferation control.
Reason: A physical interaction with an HSP70-family chaperone (mortalin) is a protein-binding-type annotation that does not describe MVD's core catalytic molecular function; it is peripheral to why MVD exists (isoprenoid synthesis). Per curation policy this experimental (IPI) annotation is not removed but is flagged as an over-annotation relative to the enzyme's function.
Supporting Evidence:
PMID:12646231
Mevalonate pyrophosphate decarboxylase (MPD) was
identified as one of the mortalin binding partners
|
|
GO:0042803
protein homodimerization activity
|
IDA
PMID:8626466 Molecular cloning and expression of the cDNAs encoding human... |
KEEP AS NON CORE |
Summary: Recombinant human MVD is a homodimer of ~43-kDa subunits.
Reason: Homodimerization is an experimentally supported structural property of the enzyme (also stated as SUBUNIT: Homodimer in UniProt), but it is a quaternary structure feature rather than MVD's core catalytic function. Retain as non-core.
Supporting Evidence:
PMID:8626466
The recombinant human enzyme is a
homodimer of 43-kDa subunits
file:human/MVD/MVD-uniprot.txt
SUBUNIT: Homodimer.
|
|
GO:0005777
peroxisome
|
IDA
NOT
PMID:14972328 Human mevalonate pyrophosphate decarboxylase is localized in... |
ACCEPT |
Summary: MVD is explicitly NOT located in the peroxisome; earlier peroxisomal claims were refuted by direct localization studies.
Reason: The negated annotation is correct and important: careful subcellular fractionation and microscopy found no peroxisomal MVD, overturning earlier reports of a peroxisomal targeting signal. UniProt records the same correction in its CAUTION note.
Supporting Evidence:
PMID:14972328
but no indication for a peroxisomal localization
file:human/MVD/MVD-uniprot.txt
However, was later shown to be cytosolic
|
|
GO:0005829
cytosol
|
IDA
PMID:14972328 Human mevalonate pyrophosphate decarboxylase is localized in... |
ACCEPT |
Summary: Direct experimental evidence that human MVD is a cytosolic protein.
Reason: The definitive localization study; MVD is cytosolic in fibroblasts, liver, CV1 and HEK293 cells by fractionation, immunofluorescence and immunoelectron microscopy.
Supporting Evidence:
PMID:14972328
We found a
cytosolic localization for both endogenous human mevalonate pyrophosphate
decarboxylase
|
Q: Beyond its metabolic role, does the MVD-mortalin (HSP70) interaction have a regulatory function on MVD stability or activity, or is it primarily relevant to mortalin-controlled proliferation?
Experiment: Structure-guided kinetic characterization of the full panel of POROK7 missense variants to quantify how each affects diphosphomevalonate decarboxylase activity and homodimer stability, correlating biochemical severity with clinical presentation.
UniProtKB: P53602 (MVD1_HUMAN), gene MVD (synonym MPD). 400 aa, ~43 kDa subunit. HGNC:7529.
MVD catalyses the final step of the mevalonate (MVA) pathway: the ATP-dependent
decarboxylation of (R)-5-diphosphomevalonate (mevalonate-5-diphosphate) to isopentenyl
diphosphate (IPP) + CO2 (+ ADP + Pi). EC 4.1.1.33; RHEA:23732.
IPP is the fundamental C5 isoprenoid building block; this reaction feeds sterol
(cholesterol) and non-sterol isoprenoid biosynthesis (dolichol, ubiquinone, prenyl
groups for protein prenylation).
- PMID:18823933
Deep research provider (falcon) was out of credits (HTTP 402) at review time; no
-deep-research-falcon.md generated. Review grounded in MVD-uniprot.txt, seeded GOA, and
cached publications/PMID_*.md (all 8 cited PMIDs present).
id: P53602
gene_symbol: MVD
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
MVD is human diphosphomevalonate decarboxylase (mevalonate-5-diphosphate
decarboxylase; EC 4.1.1.33), the enzyme that catalyses the final step of the
mevalonate pathway. It performs the ATP-dependent decarboxylation of
(R)-5-diphosphomevalonate (mevalonate-5-diphosphate) to isopentenyl
diphosphate (IPP), releasing CO2, ADP and inorganic phosphate. IPP is the
fundamental five-carbon (C5) isoprenoid building block from which all
downstream isoprenoids are assembled, so MVD sits at the point where the
mevalonate pathway delivers activated isoprene units for sterol (cholesterol)
biosynthesis and for the non-sterol isoprenoid branches (dolichol, ubiquinone,
and the prenyl groups used in protein prenylation). The protein is a member of
the GHMP kinase superfamily, binds ATP, and functions as a homodimer of
~43-kDa subunits. It is a soluble cytosolic enzyme. In humans, loss-of-function
and missense variants in MVD (together with MVK, the two principal
porokeratosis genes) cause porokeratosis (POROK7), a disorder of faulty
epidermal keratinization characterised by the cornoid lamella.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: file:human/MVD/MVD-uniprot.txt
title: UniProtKB entry P53602 (MVD1_HUMAN), Diphosphomevalonate decarboxylase
findings: []
- id: PMID:11792727
title: Absence of functional peroxisomes does not lead to deficiency of enzymes
involved in cholesterol biosynthesis.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Shows MVD (and other MVA-pathway enzymes) retain activity in
peroxisome-deficient cells; supports cytosolic function, not a specific catalytic
characterization of MVD.
- id: PMID:12646231
title: Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their
role in control of cellular proliferation.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Yeast two-hybrid / co-IP interaction between MPD (MVD) and mortalin
(mot-2/GRP75, an HSP70-family protein). Supports the Hsp70-binding IPI but this
is an interaction finding, not MVD's core molecular function.
- id: PMID:14680974
title: Cholesterol biosynthesis is not defective in peroxisome biogenesis defective
fibroblasts.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Measures MVD (MPD) activity among five presqualene MVA/isoprenoid
enzymes in PBD fibroblasts; supports enzymatic activity and cytosolic function.
- id: PMID:14972328
title: Human mevalonate pyrophosphate decarboxylase is localized in the cytosol.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Definitive subcellular localization study; MVD is cytosolic with no
peroxisomal localization. Directly supports the cytosol/NOT-peroxisome annotations.
- id: PMID:18823933
title: 'Human mevalonate diphosphate decarboxylase: characterization, investigation
of the mevalonate diphosphate binding site, and crystal structure.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Full text available. Recombinant human MDD characterization, kinetics,
active-site mutagenesis (R161, N17) and 2.4 A crystal structure (3D4J). Directly
establishes the diphosphomevalonate decarboxylase activity and reaction.
- id: PMID:8626466
title: Molecular cloning and expression of the cDNAs encoding human and yeast mevalonate
pyrophosphate decarboxylase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Cloning and expression of human MVD; recombinant enzyme is a homodimer
of 43-kDa subunits with measurable decarboxylase activity. Supports catalytic
activity and homodimerization.
- id: PMID:9270019
title: Regulation of proliferation and Ras localization in transformed cells by
products of mevalonate metabolism.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Uses 6-fluoromevalonate (Fmev, an MVD inhibitor) to block downstream
mevalonate products and Ras prenylation, suppressing proliferation. Supports a
pathway-level role in proliferation but the effect is indirect (via prenylated
products), not a direct MVD signalling function.
- id: PMID:9392419
title: Post-translational regulation of mevalonate kinase by intermediates of the
cholesterol and nonsterol isoprene biosynthetic pathways.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Expressed and assayed recombinant human MDDase (MVD) alongside MKase
and PMKase; the focus is feedback inhibition of MKase, but MVD activity and
kinetics (KM for mevalonate diphosphate) were determined. Supports catalytic
activity.
- id: Reactome:R-HSA-1655836
title: Expression of Diphosphomevalonate Decarboxylase (MVD)
findings: []
- id: Reactome:R-HSA-191414
title: MVD decarboxylates MVA5PP to IPPP
findings: []
existing_annotations:
- term:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Core catalytic molecular function of MVD, propagated by phylogenetic
inference across the diphosphomevalonate decarboxylase family and strongly
corroborated by direct human experimental evidence.
action: ACCEPT
reason: >-
This is the defining molecular function of MVD (EC 4.1.1.33): ATP-dependent
decarboxylation of (R)-5-diphosphomevalonate to isopentenyl diphosphate.
The IBA is consistent with human biochemical and structural characterization.
supported_by:
- reference_id: PMID:18823933
supporting_text: "Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "Catalyzes the ATP dependent decarboxylation of (R)-5-"
- term:
id: GO:0019287
label: isopentenyl diphosphate biosynthetic process, mevalonate pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Precise biological process for MVD: it produces isopentenyl diphosphate
(IPP) as the final step of the mevalonate pathway.
action: ACCEPT
reason: >-
MVD's product is IPP, and the enzyme catalyses the terminal mevalonate-pathway
step that generates it. This term captures the direct biological process at
the correct level of specificity and is the best core BP term.
supported_by:
- reference_id: PMID:18823933
supporting_text: "catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "Functions in\nCC the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP)"
- term:
id: GO:0005829
label: cytosol
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
MVD is a soluble cytosolic enzyme; the phylogenetically inferred cytosolic
localization matches direct human experimental evidence.
action: ACCEPT
reason: >-
Direct subcellular fractionation, immunofluorescence and immunoelectron
microscopy established a cytosolic localization for human MVD, with no
peroxisomal signal.
supported_by:
- reference_id: PMID:14972328
supporting_text: "We found a\ncytosolic localization for both endogenous human mevalonate pyrophosphate\ndecarboxylase"
- term:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Automated (ARBA/InterPro/RHEA/EC) assignment of the core catalytic function,
redundant with the experimental and IBA annotations.
action: ACCEPT
reason: >-
Correctly maps the specific diphosphomevalonate decarboxylase activity
(EC 4.1.1.33, RHEA:23732) to MVD; concordant with experimental evidence.
supported_by:
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "EC=4.1.1.33"
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Broader cytoplasmic localization from the UniProt subcellular-location
mapping; correct but less specific than cytosol.
action: ACCEPT
reason: >-
UniProt annotates MVD as cytoplasmic, consistent with its established
cytosolic localization. This parent term is correct though the more specific
GO:0005829 (cytosol) is preferred.
supported_by:
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm"
- term:
id: GO:0005829
label: cytosol
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: located_in
review:
summary: >-
Automated cytosol localization consistent with experimental evidence.
action: ACCEPT
reason: >-
Correct; MVD is cytosolic (established experimentally in PMID:14972328).
supported_by:
- reference_id: PMID:14972328
supporting_text: "but no indication for a peroxisomal localization"
- term:
id: GO:0008299
label: isoprenoid biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
Broader isoprenoid biosynthesis framing; MVD produces IPP, the universal
isoprenoid precursor.
action: ACCEPT
reason: >-
True but general parent of the more precise GO:0019287. Retained as an
accurate higher-level BP: MVD's product IPP is the substrate for all
isoprenoid biosynthesis.
supported_by:
- reference_id: PMID:18823933
supporting_text: "The reaction is required for production of polyisoprenoids and sterols from acetyl-CoA."
- term:
id: GO:0016831
label: carboxy-lyase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
Broad InterPro2GO molecular-function parent of the specific
diphosphomevalonate decarboxylase activity.
action: MODIFY
reason: >-
MVD is a decarboxylase (carboxy-lyase), so this term is not wrong, but it is
an uninformative parent of the specific GO:0004163 diphosphomevalonate
decarboxylase activity which is experimentally established. Replace with the
specific term.
proposed_replacement_terms:
- id: GO:0004163
label: diphosphomevalonate decarboxylase activity
supported_by:
- reference_id: PMID:18823933
supporting_text: "catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
- term:
id: GO:0019287
label: isopentenyl diphosphate biosynthetic process, mevalonate pathway
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
Automated (InterPro2GO) assignment of the precise mevalonate-pathway IPP
biosynthesis process, redundant with the IBA.
action: ACCEPT
reason: >-
Correct and specific; MVD produces IPP as the terminal mevalonate-pathway step.
supported_by:
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "Functions in\nCC the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP)"
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: >-
UniPathway-derived link to cholesterol biosynthesis. MVD feeds the sterol
branch but its direct product is IPP, upstream of the sterol/non-sterol
branch point.
action: KEEP_AS_NON_CORE
reason: >-
Cholesterol biosynthesis is a downstream consequence of MVD activity rather
than its direct process: MVD makes IPP, which supplies both sterol
(cholesterol) and many non-sterol isoprenoid branches (dolichol, ubiquinone,
prenyl groups). The accurate direct BP is the mevalonate-pathway IPP
biosynthesis (GO:0019287). Retain as a valid non-core downstream pathway
association.
supported_by:
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "a key precursor for the biosynthesis of isoprenoids and sterol"
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "PATHWAY: Steroid biosynthesis; cholesterol biosynthesis."
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:14972328
qualifier: is_active_in
review:
summary: >-
Experimental cytoplasmic/cytosolic localization of human MVD.
action: ACCEPT
reason: >-
Directly supported by the localization study; MVD is active in the cytosol
(cytoplasm). GO:0005829 (cytosol) is the more specific form of the same
finding.
supported_by:
- reference_id: PMID:14972328
supporting_text: "We found a\ncytosolic localization for both endogenous human mevalonate pyrophosphate\ndecarboxylase"
- term:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
evidence_type: EXP
original_reference_id: PMID:18823933
qualifier: enables
review:
summary: >-
Direct experimental characterization of recombinant human MVD's
diphosphomevalonate decarboxylase activity, including kinetics and active-site
mutagenesis, backed by a crystal structure.
action: ACCEPT
reason: >-
Gold-standard experimental support for the core catalytic function. Kinetic
parameters were measured and active-site residues (R161, N17) validated; R161Q
causes ~1000-fold loss of activity.
supported_by:
- reference_id: PMID:18823933
supporting_text: "Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
- reference_id: PMID:18823933
supporting_text: "R161Q exhibits a approximately \n1000-fold diminution in specific activity"
- term:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
evidence_type: EXP
original_reference_id: PMID:8626466
qualifier: enables
review:
summary: >-
Cloning/expression paper showing recombinant human MVD has decarboxylase
activity (2.4 units/mg).
action: ACCEPT
reason: >-
Experimental confirmation of the core catalytic function; duplicate of the
other GO:0004163 catalytic annotations.
supported_by:
- reference_id: PMID:8626466
supporting_text: "The recombinant human enzyme is a \nhomodimer of 43-kDa subunits with a specific activity of 2.4 units/mg."
- term:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
evidence_type: EXP
original_reference_id: PMID:9392419
qualifier: enables
review:
summary: >-
Recombinant human MDDase (MVD) was expressed, purified and assayed as part of
a mevalonate-pathway feedback-inhibition study.
action: ACCEPT
reason: >-
Experimental support for the decarboxylase activity; MVD's KM for
(R)-5-diphosphomevalonate was determined. Duplicate of the core catalytic
annotation.
supported_by:
- reference_id: PMID:9392419
supporting_text: "mevalonate diphosphate decarboxylase (MDDase)"
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "KM=7.4 uM for (R)-5-diphosphomevalonate {ECO:0000269|PubMed:9392419}"
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1655836
qualifier: located_in
review:
summary: >-
Reactome traceable assertion placing MVD in the cytosol.
action: ACCEPT
reason: >-
Consistent with the experimentally established cytosolic localization of MVD.
supported_by:
- reference_id: PMID:14972328
supporting_text: "Human mevalonate pyrophosphate decarboxylase is localized in the \ncytosol."
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-191414
qualifier: located_in
review:
summary: >-
Reactome traceable assertion (MVD decarboxylates MVA5PP to IPPP reaction)
placing MVD in the cytosol.
action: ACCEPT
reason: >-
Consistent with the experimentally established cytosolic localization; the
cited Reactome reaction is exactly the MVD decarboxylation of
mevalonate-5-diphosphate to IPP.
supported_by:
- reference_id: PMID:14972328
supporting_text: "Human mevalonate pyrophosphate decarboxylase is localized in the \ncytosol."
- term:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
evidence_type: IDA
original_reference_id: PMID:11792727
qualifier: enables
review:
summary: >-
MVD (MPD) decarboxylase activity measured directly in human/mouse tissue in a
study of MVA-pathway enzyme activities.
action: ACCEPT
reason: >-
Direct activity measurement of MVD supports the core catalytic function
(duplicate of the other GO:0004163 annotations).
supported_by:
- reference_id: PMID:11792727
supporting_text: "mislocalization of enzymes to the cytosol does not lead to decreased activity or"
- term:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
evidence_type: IDA
original_reference_id: PMID:14680974
qualifier: enables
review:
summary: >-
MVD (mevalonate pyrophosphate decarboxylase) activity measured directly among
presqualene MVA/isoprenoid enzymes in PBD fibroblasts.
action: ACCEPT
reason: >-
Direct activity measurement supports the core catalytic function (duplicate
of the other GO:0004163 annotations).
supported_by:
- reference_id: PMID:14680974
supporting_text: "mevalonate pyrophosphate decarboxylase"
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: NAS
original_reference_id: PMID:14680974
qualifier: involved_in
review:
summary: >-
Author-stated (NAS) placement of MVD in the cholesterol/isoprenoid
biosynthetic pathway.
action: KEEP_AS_NON_CORE
reason: >-
MVD is one of the presqualene enzymes of the cholesterol/isoprenoid pathway,
but cholesterol synthesis is downstream of MVD's direct product IPP (which
also feeds non-sterol branches). Accurate as a non-core downstream pathway
association; the precise direct BP is the mevalonate-pathway IPP biosynthesis.
supported_by:
- reference_id: PMID:14680974
supporting_text: "five different \nenzymes of the presqualene segment of the cholesterol/isoprenoid biosynthetic \npathway"
- term:
id: GO:0008284
label: positive regulation of cell population proliferation
evidence_type: IMP
original_reference_id: PMID:9270019
qualifier: involved_in
review:
summary: >-
Inhibiting MVD with 6-fluoromevalonate (Fmev) blocks production of downstream
mevalonate products, prevents Ras prenylation/membrane localization, and
suppresses proliferation of transformed cells.
action: KEEP_AS_NON_CORE
reason: >-
This is a pathway-level, indirect effect: MVD activity is required to make IPP
and hence the prenyl groups that drive Ras-dependent proliferation. It reflects
a physiological consequence of MVD's metabolic role rather than a distinct
signalling function of the protein. Retain as a non-core process rather than a
core molecular function. Per curation policy this experimental (IMP) annotation
is not removed.
supported_by:
- reference_id: PMID:9270019
supporting_text: "6-fluoromevalonate (Fmev), an inhibitor of diphosphomevalonate decarboxylase"
- reference_id: PMID:9270019
supporting_text: "completely \nprevented the proliferation of U-937 cells"
- term:
id: GO:0008299
label: isoprenoid biosynthetic process
evidence_type: IDA
original_reference_id: PMID:11792727
qualifier: involved_in
review:
summary: >-
Experimental support for MVD participation in isoprenoid/cholesterol
biosynthesis (MVA-pathway enzyme activities measured).
action: ACCEPT
reason: >-
Broad but accurate: MVD produces IPP, the universal isoprenoid precursor.
GO:0019287 is the more precise BP; this parent is retained as correct.
supported_by:
- reference_id: PMID:11792727
supporting_text: "enzymes \ninvolved in cholesterol biosynthesis"
- term:
id: GO:0008299
label: isoprenoid biosynthetic process
evidence_type: IDA
original_reference_id: PMID:14680974
qualifier: involved_in
review:
summary: >-
Experimental support for MVD participation in the cholesterol/isoprenoid
biosynthetic pathway.
action: ACCEPT
reason: >-
Accurate higher-level BP; MVD's product IPP is the isoprenoid building block.
GO:0019287 is the precise process; this parent is retained as correct.
supported_by:
- reference_id: PMID:14680974
supporting_text: "cholesterol/isoprenoid biosynthetic \npathway"
- term:
id: GO:0030544
label: Hsp70 protein binding
evidence_type: IPI
original_reference_id: PMID:12646231
qualifier: enables
review:
summary: >-
MVD (MPD) was identified in a yeast two-hybrid screen and co-IP as an
interactor of mortalin (mot-2/GRP75), a member of the HSP70 family, in a study
of proliferation control.
action: MARK_AS_OVER_ANNOTATED
reason: >-
A physical interaction with an HSP70-family chaperone (mortalin) is a
protein-binding-type annotation that does not describe MVD's core catalytic
molecular function; it is peripheral to why MVD exists (isoprenoid synthesis).
Per curation policy this experimental (IPI) annotation is not removed but is
flagged as an over-annotation relative to the enzyme's function.
supported_by:
- reference_id: PMID:12646231
supporting_text: "Mevalonate pyrophosphate decarboxylase (MPD) was \nidentified as one of the mortalin binding partners"
- term:
id: GO:0042803
label: protein homodimerization activity
evidence_type: IDA
original_reference_id: PMID:8626466
qualifier: enables
review:
summary: >-
Recombinant human MVD is a homodimer of ~43-kDa subunits.
action: KEEP_AS_NON_CORE
reason: >-
Homodimerization is an experimentally supported structural property of the
enzyme (also stated as SUBUNIT: Homodimer in UniProt), but it is a quaternary
structure feature rather than MVD's core catalytic function. Retain as non-core.
supported_by:
- reference_id: PMID:8626466
supporting_text: "The recombinant human enzyme is a \nhomodimer of 43-kDa subunits"
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "SUBUNIT: Homodimer."
- term:
id: GO:0005777
label: peroxisome
evidence_type: IDA
original_reference_id: PMID:14972328
qualifier: located_in
negated: true
review:
summary: >-
MVD is explicitly NOT located in the peroxisome; earlier peroxisomal claims
were refuted by direct localization studies.
action: ACCEPT
reason: >-
The negated annotation is correct and important: careful subcellular
fractionation and microscopy found no peroxisomal MVD, overturning earlier
reports of a peroxisomal targeting signal. UniProt records the same correction
in its CAUTION note.
supported_by:
- reference_id: PMID:14972328
supporting_text: "but no indication for a peroxisomal localization"
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "However, was later shown to be cytosolic"
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: PMID:14972328
qualifier: located_in
review:
summary: >-
Direct experimental evidence that human MVD is a cytosolic protein.
action: ACCEPT
reason: >-
The definitive localization study; MVD is cytosolic in fibroblasts, liver,
CV1 and HEK293 cells by fractionation, immunofluorescence and immunoelectron
microscopy.
supported_by:
- reference_id: PMID:14972328
supporting_text: "We found a\ncytosolic localization for both endogenous human mevalonate pyrophosphate\ndecarboxylase"
core_functions:
- description: >-
ATP-dependent decarboxylation of (R)-5-diphosphomevalonate
(mevalonate-5-diphosphate) to isopentenyl diphosphate (IPP), CO2, ADP and
phosphate, the final step of the mevalonate pathway that generates the
universal C5 isoprenoid unit.
molecular_function:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
directly_involved_in:
- id: GO:0019287
label: isopentenyl diphosphate biosynthetic process, mevalonate pathway
supported_by:
- reference_id: PMID:18823933
supporting_text: "Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
- reference_id: file:human/MVD/MVD-uniprot.txt
supporting_text: "Catalyzes the ATP dependent decarboxylation of (R)-5-"
- description: >-
As the terminal mevalonate-pathway enzyme, MVD supplies IPP for the broader
isoprenoid biosynthetic program (sterols and non-sterol isoprenoids), acting
as a soluble cytosolic enzyme.
molecular_function:
id: GO:0004163
label: diphosphomevalonate decarboxylase activity
directly_involved_in:
- id: GO:0008299
label: isoprenoid biosynthetic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:18823933
supporting_text: "The reaction is required for production of polyisoprenoids and sterols from acetyl-CoA."
- reference_id: PMID:14972328
supporting_text: "We found a\ncytosolic localization for both endogenous human mevalonate pyrophosphate\ndecarboxylase"
proposed_new_terms: []
suggested_questions:
- question: >-
Beyond its metabolic role, does the MVD-mortalin (HSP70) interaction have a
regulatory function on MVD stability or activity, or is it primarily relevant
to mortalin-controlled proliferation?
suggested_experiments:
- description: >-
Structure-guided kinetic characterization of the full panel of POROK7 missense
variants to quantify how each affects diphosphomevalonate decarboxylase
activity and homodimer stability, correlating biochemical severity with
clinical presentation.